Issue 48, 2012

Co-delivery of all-trans-retinoic-acid and cisplatin(iv) prodrug based on polymer–drug conjugates for enhanced efficacy and safety

Abstract

Toxic cisplatin and non-toxic all-trans-retinoic acid were combined in polymer platform to enhance drug efficacy and safety.

Graphical abstract: Co-delivery of all-trans-retinoic-acid and cisplatin(iv) prodrug based on polymer–drug conjugates for enhanced efficacy and safety

Article information

Article type
Paper
Submitted
06 Aug 2012
Accepted
03 Oct 2012
First published
03 Oct 2012

J. Mater. Chem., 2012,22, 25453-25462

Co-delivery of all-trans-retinoic-acid and cisplatin(IV) prodrug based on polymerdrug conjugates for enhanced efficacy and safety

R. Wang, H. Xiao, H. Song, Y. Zhang, X. Hu, Z. Xie, Y. Huang, X. Jing and Y. Li, J. Mater. Chem., 2012, 22, 25453 DOI: 10.1039/C2JM35232J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements